Treeway and uniQure Partner to Develop Gene Therapy for ALS

Entrepeneurs and ALS patients Bernard Mueller and Robert Jan Stuit are not only founders of Project MinE, the largest genetic study in ALS, but are also cofounders of an innovative ALS-focused biotechnology company called Treeway. The company now announced a partnership with gene therapy company uniQure to develop a gene therapy for ALS based on delivery of glial cell derived neurotrophic factor (GDNF). Treeway will be responsible for preclinical and clinical development of the therapy, and uniQure will provide manufacturing capabilities and expertise in gene therapy.

Click here to read more.

disease-als topic-clinical topic-preclinical topic-randd
Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail